Recruiting
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
NCT07401875
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, HC-7366, +12 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States